NCT01876810View on ClinicalTrials.gov

Initial Screening of Gemfibrozil as a Novel Treatment for Tobacco Addiction

PHASE2CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions
Nicotine Dependence
Interventions
DRUG

Gemfibrozil

600 mg of gemfibrozil (one capsule) twice daily for two weeks.

DRUG

Placebo

One lactose pill twice a day for two weeks.

Trial Locations (2)

M5S 1S8

Centre for Addiction and Mental Health, Toronto

M5S 2S1

Centre of Addiction and Mental Health, Toronto

All Listed Sponsors
lead

Centre for Addiction and Mental Health

OTHER

NCT01876810 - Initial Screening of Gemfibrozil as a Novel Treatment for Tobacco Addiction | Biotech Hunter | Biotech Hunter